Literature DB >> 8709204

The CR1 and CR3 domains of the adenovirus type 5 E1A proteins can independently mediate activation of ATF-2.

M C Duyndam1, H van Dam, A J van der Eb, A Zantema.   

Abstract

The adenovirus 12S E1A protein can stimulate the activity of the c-jun promoter through a conserved region 1 (CR1)-dependent mechanism. The effect is mediated by two AP-1/ATF-like elements, jun1 and jun2, that preferentially bind c-Jun-ATF-2 heterodimers. In this study, we show that the ATF-2 component of the c-Jun-ATF-2 heterodimer is the primary target for 12S E1A: 12S E1A can enhance the transactivating activity of the N terminus of ATF-2 when fused to a heterologous DNA-binding domain, whereas the transactivating activity of the c-Jun N terminus is not significantly affected. Activation of the ATF-2 N terminus by 12S E1A is dependent on CR1. In the context of the 13S E1A protein, CR1 and CR3 can both contribute to activation of ATF-2, and their relative contributions are dependent on the cell type. In contrast to activation of ATF-2 by stress-inducing agents, CR1-dependent activation of ATF-2 was found not to depend strictly on the presence of threonines 69 and 71 in the N terminus of ATF-2, which are targets for phosphorylation by stress-activated protein kinases (SAPKs). In agreement with this observation, we did not observe phosphorylation of threonines 69 and 71 or constitutively enhanced SAPK activity in E1A- plus E1B-transformed cell lines. These data suggest that CR1-dependent activation of ATF-2 by 12S E1A does not require phosphorylation of threonines 69 and 71 by SAPK.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709204      PMCID: PMC190602          DOI: 10.1128/JVI.70.9.5852-5859.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

2.  Transformation of rat cells by DNA of human adenovirus 5.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

3.  Nuclear protein CBP is a coactivator for the transcription factor CREB.

Authors:  R P Kwok; J R Lundblad; J C Chrivia; J P Richards; H P Bächinger; R G Brennan; S G Roberts; M R Green; R H Goodman
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

4.  Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

Authors:  F Liu; M R Green
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

5.  CBF mediates adenovirus Ela trans-activation by interaction at the C-terminal promoter targeting domain of conserved region 3.

Authors:  S N Agoff; B Wu
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

6.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  The stress-activated protein kinase subfamily of c-Jun kinases.

Authors:  J M Kyriakis; P Banerjee; E Nikolakaki; T Dai; E A Rubie; M F Ahmad; J Avruch; J R Woodgett
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

8.  Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.

Authors:  J Arias; A S Alberts; P Brindle; F X Claret; T Smeal; M Karin; J Feramisco; M Montminy
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

9.  A TATA box implicated in E1A transcriptional activation of a simple adenovirus 2 promoter.

Authors:  L Wu; D S Rosser; M C Schmidt; A Berk
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

10.  Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation.

Authors:  J F Schneider; F Fisher; C R Goding; N C Jones
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  7 in total

1.  GAGA can mediate enhancer function in trans by linking two separate DNA molecules.

Authors:  Tokameh Mahmoudi; Katerina R Katsani; C Peter Verrijzer
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.

Authors:  H van Dam; S Huguier; K Kooistra; J Baguet; E Vial; A J van der Eb; P Herrlich; P Angel; M Castellazzi
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

3.  TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage.

Authors:  S G Cho; A Bhoumik; L Broday; V Ivanov; B Rosenstein; Z Ronai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Mimicry of Cellular A Kinase-Anchoring Proteins Is a Conserved and Critical Function of E1A across Various Human Adenovirus Species.

Authors:  Cason R King; Steven F Gameiro; Tanner M Tessier; Ali Zhang; Joe S Mymryk
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells.

Authors:  H Kawasaki; J Song; R Eckner; H Ugai; R Chiu; K Taira; Y Shi; N Jones; K K Yokoyama
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

6.  Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.

Authors:  D Margriet Ouwens; Nancy D de Ruiter; Gerard C M van der Zon; Andrew P Carter; Jan Schouten; Corina van der Burgt; Klaas Kooistra; Johannes L Bos; J Antonie Maassen; Hans van Dam
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

7.  Viral retasking of hBre1/RNF20 to recruit hPaf1 for transcriptional activation.

Authors:  Gregory J Fonseca; Michael J Cohen; Anthony C Nichols; John W Barrett; Joe S Mymryk
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.